Yossi Maimon, VP, Chief Financial Officer at Protalix BioTherapeutics, Inc. (PLX), sold 66,500 shares at $2.23 ($147K) on 2009-03-13, disclosed to the SEC on 2009-03-13.
Open-market sale of $147k PLX by VP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.30 | 8,849 | $20K | 13.8% |
| 2 | $2.22 | 32,241 | $72K | 48.6% |
| 3 | $2.16 | 17,910 | $39K | 26.3% |
| 4 | $2.23 | 7,500 | $17K | 11.4% |
| Total | $2.22 avg | 66,500 | $147K | 100% |
| Filing → |
| PLX | SELL | 2010-10-08 | $677K | — | Filing → |
| PLX | SELL | 2010-09-08 | $565K | — | Filing → |
| PLX | SELL | 2009-10-19 | $1.4M | — | Filing → |